Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-01-04 @ 9:07 PM
Study NCT ID:
NCT00179660
Status:
COMPLETED
Last Update Posted:
2016-01-21
First Post:
2005-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)
Sponsor:
Celgene Corporation
Organization: